drugset / Trial / NCT00764634
Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
RandomizedParallel-groupTriple-blind
Summary
This Phase 2 study is a double blind, placebo-controlled, randomized, multicenter investigation of rBV A/B-40 vaccine or placebo in healthy adults, using two different three-dose dosing schedules.
Timeline
- Start
- 2008-09
- Primary completion
- 2010-03
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | rBV A/B-40 | Vaccine | 0.5 ml | Intramuscular |